A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...

Stem cell research offers unprecedented opportunities for developing new medical therapies for debilitating diseases and a new way to explore fundamental questions of biology. Stem cells are ...

Stem cells in most organisms typically take cues from adjacent cells. But new research from the Stowers Institute for Medical Research has found that stem cells in the freshwater planarian Schmidtea ...

NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.

Comprehensive review led by R3’s Department of Research consolidates emerging evidence on Wharton’s jelly function, ...

New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized methodologies for deriving induced ...

An “immune system reset” cured autoimmune, or Type 1, diabetes in mice in a Stanford Medicine study. The approach may be useful for other autoimmune conditions as well as organ transplants.

A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely ...

Researchers have identified a shared protein checkpoint, GSK3α, that maintains stem cell identity across multiple types, potentially streamlining lab cultivation for therapies. In a separate advance, ...

Just as the world learns that researchers in South Korea have successfully extracted stem cells from cloned embryos, Congress is considering a bill a to expand the use of federal funds to harvest stem ...

For the first time, a stem cell model has produced a structure resembling an early human embryo with a yolk-sac-like structure, from a single starting stem cell population and without direct genetic ...